register | login
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2022 Medicom Conference Planning
  • Disease Areas
  • Other Medical News
  • Podcast
  • Videos
  • Education
  • About
    • Vacancies

Tag: Diffuse Large B Cell Lymphoma

Axi-cel improved event-free survival in R/R DLBCL

Presented By
Dr Frederick Locke, Moffitt Cancer Cancer, FL, USA
Trial
Phase 3, ZUMA-7
Conference
ASH 2021

4 February, 2022 11:09

Novel anti-CD19 plus lenalidomide prolonged survival in R/R DLBCL

Expert
Dr Grzegorz Nowakowski, Mayo Clinic, Rochester, USA
Trial
Cohort study, RE-MIND2
Conference
ASH 2021

4 February, 2022 11:08

Axi-cel more effective but tisa-cel less toxic in DLBCL

Presented By
Dr Emmanuel Bachy, Hospices Civils de Lyon, France
Conference
ASH 2021

4 February, 2022 11:01

POLARIX: Novel regimen superior to R-CHOP in DLBCL

Presented By
Prof. Hervé Tilly, University of Rouen, France
Trial
Phase 3, POLARIX
Conference
ASH 2021

4 February, 2022 10:56

CIRS is predictive of outcomes in CAR T-cell recipients with R/R DLBCL

Expert
Dr Geoffrey Shouse, City of Hope Comprehensive Cancer Center, USA
Conference
ASH 2021

4 February, 2022 10:20

Comparable outcomes with second-line tisa-cel versus standard-of-care for relapsed/refractory aggressive NHL

Expert
Dr Michael R. Bishop, David and Etta Jonas Center for Cellular Therapy, University of Chicago, USA
Trial
Phase 3, BELINDA
Conference
ASH 2021

4 February, 2022 10:03

Mutational analyses are predictive in malignant lymphomas

Presented By
Dr Ismael Fernández-Miranda, Institute of Sanitary Investigation Puerta de Hierro, Spain & Dr Shan-Shan Li, Hospital of Sun Yat-sen University, China
Conference
ESMO 2021

19 November, 2021 09:19

Escalating the ESCALADE trial: untreated diffuse large B-cell lymphoma

Presented By
Dr Laurie Sehn, University of British Columbia, Vancouver, Canada
Trial
Phase 3, ESCALADE
Journal
Physician's Weekly
Conference
ASCO 2021

6 August, 2021 12:36

Naratuximab emtansine + rituximab safe and effective in diffuse large B-cell lymphoma

Presented By
Dr Moshe Yair Levy, Texas Oncology-Baylor Charles A. Sammons Cancer Center, USA
Conference
EHA 2021

5 August, 2021 11:55

Promising chemo-free treatment options in r/r DLBCL

Presented By
Prof. Marco Ladetto, University del Piemonte Orientale, Italy
Trial
LOTIS-2
Conference
EHA 2021

5 August, 2021 11:17

Infectious complications mild and not common in patients receiving CAR-T therapy for diffuse large B cell lymphoma

Presented By
Dr Roberta Di Blasi, Hospital Saint-Louis, France
Trial
JULIET and ZUMA1
Conference
EHA 2019

9 August, 2019 19:55

Obinutuzumab/polatuzumab in follicular lymphoma

Presented By
Prof. Wojciech Jurczak, Jagiellonian University, Poland
Conference
EHA 2019

9 August, 2019 17:13
site created by:   

© 2021 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT